Afip Medicina Diagnóstica

What Afip Medicina Diagnóstica does

Afip Medicina Diagnóstica (legal entity: Associação Fundo de Incentivo à Pesquisa) is a private, non-profit, philanthropic diagnostic medicine institution headquartered in São Paulo, Brazil, founded in the 1970s by physicians, researchers, and university professors. It operates as an integrated diagnostic platform offering more than 4,000 examination types spanning clinical analyses, imaging (densitometry, mammography, X-ray, CT, ultrasound), molecular biology, genetics, immunogenetics, and personalized medicine, anchored by a 7,500 m² Núcleo Técnico Operacional (NTO) Central in São Paulo with capacity to process 10 million exams per month. The institution extends nationally through 50 satellite NTOs embedded in client municipalities and hospitals, executing 1,000+ daily collections across 200+ cities, and is recognized as the largest clinical analysis laboratory in Brazil's public Unified Health System (SUS) ambulatory network. Specialized capabilities include the IGEN immunogenetics unit (the first EFI-accredited laboratory in Brazil for solid organ and bone marrow transplants, serving 14,000+ patients on the kidney transplant list at Hospital do Rim), an internally developed dd-cfDNA transplant rejection test (the only one offered in Brazil), a Biosafety Level 3 (NB3) laboratory, and the NASCIH hospital infection surveillance service used by more than 40 hospitals and 600+ healthcare units.

The business model operates on a transaction-fee (per-examination) basis, with revenue generated from public-sector contracts with municipal and state governments under SUS procurement, private enterprise contracts with hospitals, laboratories, and clinics, and walk-in patient revenue at diagnostic centers in São Paulo, Cuiabá, Jundiaí, and Santos. Pricing is not publicly disclosed and is negotiated per contract. Distribution is enterprise field sales-led, with direct contracts to SUS health secretariats and dedicated account management for major hospital clients. A newly hired Commercial Director (Renato Fernandez) is leading a deliberate push to expand private-sector business, complemented by an Innovation Director focused on new methods and products. AFIP is CEBAS-certified (charitable social assistance entity) and holds ONA Level 3 Excellence, PALC, and EFI accreditations, generating 16.29x social return on its tax immunity — 2.4x the average of Brazilian health philanthropics. The 2024 leadership transition installed a new CEO (Sergio Brasil Tufik) and CFO (Raphael Romanini), and the company continues to invest in proprietary molecular biology R&D, with 50+ international scientific publications and 20 studies accepted at ADLM 2025, two receiving scientific excellence awards.

Name

Afip Medicina Diagnóstica

Legal name

Associação Fundo de Incentivo à Pesquisa

Website

https://afipdiagnostica.com.br

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Afip Medicina Diagnóstica is a São Paulo-based, non-profit philanthropic diagnostic laboratory platform operating a 7,500 m² central NTO and 50 satellite NTOs across 200+ Brazilian cities, serving SUS public health clients, private hospitals, and walk-in patients with clinical, molecular, and imaging diagnostics.

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

akta.pro secondary industry

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• Diagnostic laboratory services
• Clinical analysis
• Molecular diagnostics
• Transplant immunogenetics
• Medical imaging services

Headquarters

HQ city

Saúde

HQ country

Brazil

HQ region

Latin America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Clinical Analysis and Diagnostic Services: Core revenue stream from laboratory diagnostic services including clinical analyses, imaging, specialized tests, and personalized medicine. Services are contracted by public clients (municipal/state governments, SUS-funded institutions) and private clients (hospitals, laboratories, clinics). Revenue is generated through service contracts and per-examination pricing under public procurement frameworks and private agreements.
2. Specialized Diagnostic Services: Revenue from specialized high-complexity services including NB3 biosafety laboratory, dd-cfDNA transplant monitoring, genetics, immunogenetics (IGEN), and molecular diagnostics. These premium services are provided to hospital and transplant center clients.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

Afip Medicina Diagnóstica provides diagnostic laboratory and clinical analysis services through a centralized Núcleo Técnico Operacional (NTO) facility in São Paulo, complemented by a national network of satellite collection units and diagnostic centers. Its offering spans clinical analysis, diagnostic imaging, molecular diagnostics, immunogenetics (IGEN) for transplant support, hospital infection control (NASCIH), polysomnography, telemedicine, and specialized tests such as dd-cfDNA transplant monitoring and non-invasive prenatal paternity testing. Services are delivered to public health system (SUS) clients, private hospitals and clinics, and individual patients.

Product overview

AFIP Medicina Diagnóstica is a private, non-profit, philanthropic institution founded in the 1970s by doctors, researchers, and university professors. It operates as a unified platform of diagnostic medicine services rather than a single product, offering integrated solutions through multiple specialized units and service categories. The core offerings include Coleta e Análises Clínicas (Clinical Analysis and Collection) with decentralized sample collection and central processing at the NTO (Núcleo Técnico Operacional), supported by imaging services, specialized tests, and personalized medicine. Key specialized units include IGEN (Instituto de Imunogenética) for histocompatibility and transplant immunology, NASCIH for hospital infection control, and NB3 for Biosafety Level 3 research. The NTO Central operates in 7,500 m² in São Paulo with capacity for 120 million exams per year. Services are delivered to public and private clients nationwide through diagnostic centers, satellite NTOs, and hospital partnerships, with over 200 cities and 50 NTOs serving the network.

Differentiator

Problem solved

Functional benefit

Brands

• IGEN - Instituto de Imunogenética: Instituto de Imunogenética com reconhecimento nacional e internacional em Histocompatibilidade, Imunogenética e Imunologia dos Transplantes. Primeiro laboratório do Brasil a conquistar a Acreditação da Federação Europeia de Imunogenética (EFI).
• NASCIH
• NTO - Núcleo Técnico Operacional

Products and services

• Clinical Analysis Laboratory Services High-volume centralized clinical laboratory analysis services (clinical chemistry, hematology, immunology, microbiology) processing up to 10 million exams monthly through the São Paulo-based NTO Central, with samples collected across a national satellite network.
• Diagnostic Imaging Services Imaging exam services delivered at Diagnostics Brasil diagnostic centers for both institutional referrals and individual patients.
• IGEN Immunogenetics Laboratory (Transplant) EFI-accredited immunogenetics laboratory supporting transplant programs, including the only Brazilian dd-cfDNA transplant monitoring test, serving transplant centers and reference hospitals.
• NASCIH Hospital Infection Control Support Specialized laboratory support service for hospital infection control, providing molecular epidemiology tools, surveillance, and outbreak response to healthcare institutions.
• DD-cfDNA Transplant Monitoring Test Donor-derived cell-free DNA test offered exclusively in Brazil through the EFI-accredited IGEN laboratory for transplant rejection monitoring.
• Non-Invasive Prenatal Paternity Test Next-generation sequencing-based non-invasive prenatal paternity test for individual consumers and referring physicians.
• Polysomnography Sleep study service offered at diagnostic centers for individual patient evaluation of sleep disorders.
• Telemedicine Services Remote diagnostic consultation and report delivery services complementing laboratory and imaging offerings.
• Diagnostics Brasil Walk-in Diagnostic Centers Patient-facing diagnostic centers providing direct access to clinical analyses, imaging exams, polysomnography, and specialized tests for individual consumers and referring physicians.
• Genetics and Personalized Medicine Tests Genetic testing services supporting personalized medicine applications for clinical partners and patients.
• Mobile and Specialized Home Collection Service Mobile sample collection service bringing diagnostic testing to patients and institutional clients with specialized handling protocols linked to the central NTO processing lab.

Quantifiable outcome

• 16.29x social return on tax immunity investment, 2.4x higher than sector average
• +6 more outcomes

Named customers13 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Partnerships

One partnership is on record.

• Brasil ApoiocoreStrategic or Co-development PartnerBrasil Apoio is a related entity that AFIP directs clients to for its laboratorial support and center of diagnostics solutions pages. The partnership involves coordinated delivery of diagnostic services under the Brasil Apoio brand, with AFIP providing the analytical laboratory infrastructure and Brasil Apoio managing client-facing operations and service coordination.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Synlab: Synlab is Europe's largest clinical laboratory services provider with operations in multiple Latin American markets, offering routine and specialized diagnostic testing at scale. It serves as a global benchmark for AFIP on operational scale, network logistics, and specialty diagnostics commercialization.
• Quest Diagnostics: Quest Diagnostics is one of the world's largest clinical laboratory networks, providing routine and esoteric testing with strong advanced diagnostics capabilities. It serves as a global benchmark for AFIP's scale ambitions, molecular diagnostics investment, and specialty test menu breadth.
• Unilabs: Unilabs is a European-headquartered clinical laboratory group operating in over 75 countries with strong specialty diagnostics and hospital partnership models. Comparable to AFIP in its mix of public-health contracts, hospital service agreements, and growing specialty testing focus.
• Hospital Israelita Albert Einstein: Hospital Israelita Albert Einstein operates one of Brazil's most prestigious diagnostic medicine services within a broader hospital system. AFIP's CEO Sergio Brasil Tufik trained at Einstein, and Einstein serves as a benchmark for clinical quality and specialized testing capabilities across both private and SUS patient populations.
• Hospital Sírio-Libanês: Hospital Sírio-Libanês operates high-complexity diagnostic services embedded within a broader premium hospital system. It competes with AFIP for high-complexity specialty testing (oncology, genetics, transplant support) as part of a larger integrated care offering rather than as a standalone laboratory.
• Rede D'Or São Luiz: Rede D'Or São Luiz is Brazil's largest hospital network and operates in-house diagnostic laboratory services across its facilities. As both a current AFIP client category and a potential competitor through insourcing, Rede D'Or represents an important comparable for integrated hospital-based diagnostics delivery.

Direct peers

• Dasa: Dasa is the largest diagnostic medicine company in Brazil, offering clinical analysis, imaging, and molecular diagnostics to both public and private clients across hundreds of units. It is the most directly comparable for-profit counterpart to AFIP's clinical laboratory services.
• Grupo Alliar: Grupo Alliar is a Brazilian diagnostic imaging center network with significant national presence and hospital partnerships. AFIP's CEO Sergio Brasil Tufik previously trained at Alliar, and AFIP operates imaging services (X-ray, CT, ultrasound, mammography) that overlap with Alliar's core offerings.
• Grupo Fleury: Grupo Fleury is a major Brazilian diagnostic medicine chain with a broad portfolio of clinical analyses, imaging, and specialized tests serving both private and institutional clients. It competes head-to-head with AFIP in clinical laboratory services and hospital partnerships across Brazil.
• Sabin Diagnóstico e Saúde: Sabin is a Brazilian diagnostic medicine group operating clinical analysis labs, imaging centers, and specialized testing services with nationwide reach. It directly competes with AFIP in clinical laboratory services and is comparable in scale and geographic coverage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@afipmedicinadiagnostica
• Facebookfacebook.com/afipmedicinadiagnostica
• LinkedInlinkedin.com/company/afipmedicinadiagnostica
• Instagraminstagram.com/afipmedicinadiagnostica

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Afip Medicina Diagnóstica